Long-term course of brain-derived neurotrophic factor serum levels in a patient treated with deep brain stimulation of the lateral habenula

Introduction: According to the neurotrophin hypothesis, a brain-derived neurotrophic factor (BDNF) decrease has been postulated as a pivotal pathomechanism in affective disorder, and the treatment-associated increase in peripheral BDNF has been linked to therapeutic efficacy of antidepressant drugs...

Full description

Saved in:
Bibliographic Details
Main Authors: Hoyer, Carolin (Author) , Sartorius, Alexander (Author) , Gass, Peter (Author)
Format: Article (Journal)
Language:English
Published: February 25, 2012
In: Neuropsychobiology
Year: 2012, Volume: 65, Issue: 3, Pages: 147-152
ISSN:1423-0224
DOI:10.1159/000335243
Online Access:Verlag, Volltext: http://dx.doi.org/10.1159/000335243
Verlag, Volltext: https://www-karger-com.ezproxy.medma.uni-heidelberg.de/Article/FullText/335243
Get full text
Author Notes:Carolin Hoyer, Laura Kranaster, Alexander Sartorius, Rainer Hellweg, Peter Gass
Description
Summary:Introduction: According to the neurotrophin hypothesis, a brain-derived neurotrophic factor (BDNF) decrease has been postulated as a pivotal pathomechanism in affective disorder, and the treatment-associated increase in peripheral BDNF has been linked to therapeutic efficacy of antidepressant drugs and electroconvulsive therapy. However, in deep brain stimulation (DBS), a still experimental antidepressant treatment approach, this issue has not yet been investigated. Methods: We examine the long-term course of serum BDNF levels in a 64-year-old woman who is being treated with DBS of the lateral habenula for severe major depressive disorder. Results: Our main findings are a significant increase in BDNF serum levels following DBS of the lateral habenula and an inverse U-shaped correlation of depression scores and BDNF levels. Discussion: The data indicate that DBS, like other effective antidepressant treatments, may contribute to an increase in peripheral BDNF levels, which are thought to reflect central nervous DBS-induced neuroplastic changes. Moreover, our observations underscore the complex nature of disease-associated BDNF alterations. Their identification as either state or trait marker remains controversial and requires larger-scale longitudinal studies.
Item Description:Gesehen am 18.04.2018
Physical Description:Online Resource
ISSN:1423-0224
DOI:10.1159/000335243